Actinogen Medical (ASX:ACW) receives FDA approval for six-month phase 2b Alzheimer trial
Actinogen Medical (ACW) has received approval from the US Food and Drug…
Change | ||
S&P/ASX Sm. Ords. | |||
All Ordinaries | |||
S&P/ASX 100 |
NIM | NIMY RESOURCES LIMITED | 7.2¢ | 63.6% |
KNB | KOONENBERRY GOLD LIMITED | 3.2¢ | 60.0% |
RCL | READCLOUD LIMITED | 6.0¢ | 33.3% |
KOR | KORAB RESOURCES LIMITED | 0.7¢ | 30.0% |
BNZ | BENZ MINING CORP. | 18.0¢ | 20.0% |
AYA | ARTRYA LIMITED | 29.0¢ | 19.4% |